|
🐜
|
Type I interferon inhibits interleukin-1 production and inflammasome activation.
11 auth.
Greta Guarda,
M. Braun,
Francesco Staehli,
A. Tardivel,
C. Mattmann,
I. Förster,
...
Matthias Farlik,
T. Decker,
R. D. Du Pasquier,
P. Romero,
J. Tschopp
|
9 |
2011 |
9
🐜
|
|
🐜
|
NLRC5 Deficiency Selectively Impairs MHC Class I- Dependent Lymphocyte Killing by Cytotoxic T Cells
15 auth.
Francesco Staehli,
K. Ludigs,
L. Heinz,
Queralt Seguín-Estévez,
I. Ferrero,
M. Braun,
K. Schroder,
Manuele Rebsamen,
A. Tardivel,
C. Mattmann,
...
H. Macdonald,
P. Romero,
W. Reith,
Greta Guarda,
J. Tschopp
|
7 |
2012 |
7
🐜
|
|
🐜
|
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.
17 auth.
C. Reissfelder,
Slava Stamova,
Christina Gossmann,
M. Braun,
A. Bonertz,
Ute Walliczek,
M. Grimm,
N. Rahbari,
M. Koch,
Maral Saadati,
...
A. Benner,
M. Büchler,
D. Jäger,
N. Halama,
K. Khazaie,
J. Weitz,
P. Beckhove
|
6 |
2015 |
6
🐜
|
|
🐜
|
Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets
17 auth.
B. Salaun,
Takuya Yamamoto,
B. Badran,
Y. Tsunetsugu-Yokota,
A. Roux,
L. Baitsch,
R. Rouas,
H. Fayyad-kazan,
Petra Baumgaertner,
Estelle F. Devêvre,
...
A. Ramesh,
M. Braun,
D. Speiser,
B. Autran,
P. Martiat,
V. Appay,
P. Romero
|
6 |
2011 |
6
🐜
|
|
🦁
|
Virus‐like particles induce robust human T‐helper cell responses
8 auth.
M. Braun,
C. Jandus,
Patrik Maurer,
A. Hammann-Haenni,
K. Schwarz,
M. Bachmann,
...
D. Speiser,
P. Romero
|
6 |
2012 |
6
🦁
|
|
🐜
|
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
18 auth.
Petra Baumgaertner,
C. C. Nunes,
A. Cachot,
H. M. Hajjami,
Laurène Cagnon,
M. Braun,
L. Derré,
J. Rivals,
D. Rimoldi,
S. Gnjatic,
...
S. A. Maillard,
P. M. Mondéjar,
M. Protti,
E. Romano,
O. Michielin,
P. Romero,
D. Speiser,
C. Jandus
|
5 |
2016 |
5
🐜
|
|
🐬
|
Quantitative analysis of cancer invasion in vitro: comparison of two new assays and of tumour sublines with different metastatic capacity
C. Waller,
M. Braun,
V. Schirrmacher
|
3 |
1986 |
3
🐬
|
|
🐜
|
Corrigendum. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.
17 auth.
Christoph Reissfelder,
Slava Stamova,
Christina Gossmann,
M. Braun,
A. Bonertz,
Ute Walliczek,
M. Grimm,
N. Rahbari,
M. Koch,
Maral Saadati,
...
A. Benner,
M. Büchler,
D. Jäger,
N. Halama,
K. Khazaie,
J. Weitz,
P. Beckhove
|
2 |
2015 |
2
🐜
|
|
🦁
|
Peptide and Protein-Based Cancer Vaccines
M. Braun,
R. Perret,
Godehard A. Scholz,
P. Romero
|
1 |
2013 |
1
🦁
|
|
🐜
|
Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope
14 auth.
P. Baumgartner,
C. C. Nunes,
A. Cachot,
H. M. Hajjami,
Laurène Cagnon,
M. Braun,
L. Derré,
J. Rivals,
D. Rimoldi,
E. Romano,
...
O. Michielin,
P. Romero,
C. Jandus,
D. Speiser
|
1 |
2015 |
1
🐜
|
